Loading company
Latest annual · FY2025
Millions- Total revenues
- 1
- Gross profit
- (2)
- Operating income
- (30)
- Net income
- (26)
- Free cash flow
- (33)
Latest quarter · Q2 FY2026
Millions- Total revenues
- 0
- Operating income
- (3)
- Net income
- (3)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- +6.1%
- Revenue, 5 yearsFY2020 to FY2025
- -51.4%
- Net income, 5 yearsFY2020 to FY2025
- n/m
Yarrow Bioscience, Inc. (YARW) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $570,000 | $501,000 | +13.8% | 10-K 2026-02-27 · proof |
| Operating income | -$29.7 million | -$43.6 million | 10-K 2026-02-27 · proof | |
| Net income | -$26.5 million | -$39.8 million | 10-K 2026-02-27 · proof | |
| Cash from operating activities | -$33.1 million | -$34 million | 10-K 2026-02-27 · proof | |
| Free cash flow | -$33.1 million | -$34.1 million | 10-K 2026-02-27 · proof |
- What was Yarrow Bioscience, Inc. (YARW)'s revenue in fiscal 2025?
- Yarrow Bioscience, Inc. (YARW) reported revenue of $570,000 for fiscal 2025 (the year ended Dec 31, 2025), against $501,000 the year before (+13.8%). Source: the 10-K filed with the SEC on Feb 27, 2026. SEC
- What was Yarrow Bioscience, Inc. (YARW)'s operating income in fiscal 2025?
- Yarrow Bioscience, Inc. (YARW) reported operating income of -$29.7 million for fiscal 2025 (the year ended Dec 31, 2025), against -$43.6 million the year before. Source: the 10-K filed with the SEC on Feb 27, 2026. SEC
- What was Yarrow Bioscience, Inc. (YARW)'s net income in fiscal 2025?
- Yarrow Bioscience, Inc. (YARW) reported net income of -$26.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -$39.8 million the year before. Source: the 10-K filed with the SEC on Feb 27, 2026. SEC
- What was Yarrow Bioscience, Inc. (YARW)'s cash from operating activities in fiscal 2025?
- Yarrow Bioscience, Inc. (YARW) reported cash from operating activities of -$33.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$34 million the year before. Source: the 10-K filed with the SEC on Feb 27, 2026. SEC
- What was Yarrow Bioscience, Inc. (YARW)'s free cash flow in fiscal 2025?
- Yarrow Bioscience, Inc. (YARW) reported free cash flow of -$33.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$34.1 million the year before. Source: the 10-K filed with the SEC on Feb 27, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:YARW&period_type=annual&limit=5"Information only, not investment advice.